Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Category: Diabetes

1242-OR: Cannabinoid Receptor 2 Agonism Decreases Retinal Inflammation and Is Neuroprotective in Diabetic Retinopathy Models

June 12, 2026 by sugaradmin

Introduction and Objective: Early diabetic retinopathy (DR) is associated with inflammation and retinal neurodegeneration, which begin prior to overt microvascular pathology. Cannabinoid (CB) receptor 2 agonism has been shown to have anti-inflammatory and neuroprotective properties in the central nervous system. This study tested the potential of CB2-selective agonists HU-308 and CB65 to reduce inflammation and […]

Read More
DiabetesLeave a Comment on 1242-OR: Cannabinoid Receptor 2 Agonism Decreases Retinal Inflammation and Is Neuroprotective in Diabetic Retinopathy Models

1235-OR: Gestational Diabetes Diagnosis Using Continuous Glucose Monitoring at 24–28 Weeks’ Gestation

June 12, 2026 by sugaradmin

Introduction and Objective: Data are limited as to whether continuous glucose monitoring (CGM) can be used to accurately diagnose gestational diabetes mellitus (GDM). We aimed to develop GDM diagnostic criteria based on CGM metrics at 24-28 weeks’ gestation.Methods: Planned analysis of a longitudinal, multi-site prospective cohort of gravidas without pregestational diabetes who wore a blinded […]

Read More
DiabetesLeave a Comment on 1235-OR: Gestational Diabetes Diagnosis Using Continuous Glucose Monitoring at 24–28 Weeks’ Gestation

1228-OR: First-in-Human Study Demonstrates GIP Receptor (GIPR) Antagonist AT7687 as Well-Tolerated and Suitable for Once-Weekly Subcutaneous Injection for Treatment in People Living with Obesity

June 12, 2026 by sugaradmin

Introduction and Objective: AT7687 is a first-in-class peptide GIPR antagonist validated as anti-obesity therapy in obese monkeys, as monotherapy and in combination with liraglutide and cagrilintide. This randomized, double-blind, placebo-controlled study evaluated the safety, pharmacokinetics (PK), and pharmacodynamics of AT7687 (AT).Methods: In the single ascending dose (SAD) part, 60 participants randomized 6:2 by cohort received […]

Read More
DiabetesLeave a Comment on 1228-OR: First-in-Human Study Demonstrates GIP Receptor (GIPR) Antagonist AT7687 as Well-Tolerated and Suitable for Once-Weekly Subcutaneous Injection for Treatment in People Living with Obesity

1265-OR: Tirzepatide: Effect on Insulin Resistance and Human Fat Cells

June 12, 2026 by sugaradmin

Introduction and Objective: We tested the hypothesis that tirzepatide (TZ), a dual GLP-1/GIP agonist, improves metabolic health independent of weight loss via GIP effects on adipose cells. Dual GLP-1/GIP agonists are known to lower blood glucose to a greater degree than selective GLP-1 agonists. We quantified insulin resistance (IR) and adipose cell function after 6 […]

Read More
DiabetesLeave a Comment on 1265-OR: Tirzepatide: Effect on Insulin Resistance and Human Fat Cells

1264-OR: Launch of the First Fully Remote Type 1 Diabetes Screening Program: Integration of a Novel, Scalable Genetic Risk Score and At-Home Monitoring with Autoantibody Testing and Psychosocial Support

June 12, 2026 by sugaradmin

Introduction and Objective: Early type 1 diabetes (T1D) detection is vital to prevent DKA, which affects 60% of pediatric cases. However, traditional screening relies on invasive blood draws, limiting accessibility for young children. We launched the first “fully remote” T1D screening program designed for large-scale implementation using a novel genetic stratification tool alongside online monitoring […]

Read More
DiabetesLeave a Comment on 1264-OR: Launch of the First Fully Remote Type 1 Diabetes Screening Program: Integration of a Novel, Scalable Genetic Risk Score and At-Home Monitoring with Autoantibody Testing and Psychosocial Support

1250-OR: Efficacy of a Food Is Medicine Program in Low-Income, High-Risk Adults with Type 2 Diabetes: The KP ENRICH Study

June 12, 2026 by sugaradmin

Introduction and Objective: Food Is Medicine interventions are being promoted to improve glycemic control in type 2 diabetes mellitus (T2D), but limited randomized trial (RCT) data exist. We evaluated the efficacy of a scalable, technology-based grocery prescription program in low-income, high-risk adults with T2D.Methods: We conducted a 1:1 RCT in Kaiser Permanente Northern & Southern […]

Read More
DiabetesLeave a Comment on 1250-OR: Efficacy of a Food Is Medicine Program in Low-Income, High-Risk Adults with Type 2 Diabetes: The KP ENRICH Study

1249-OR: Medically Tailored Meals Lower Hemoglobin A1c: The Food as Medicine for Diabetes (FAME-D) Randomized Clinical Trial

June 12, 2026 by sugaradmin

Introduction and Objective: Food insecurity leads to worse type 2 diabetes (T2D) outcomes, but which food insecurity intervention best improves T2D outcomes is unclear. Our objective was to compare the effectiveness of two food insecurity interventions: medically tailored meals (MTM) and food subsidies.Methods: Randomized comparative effectiveness trial (NCT04828785). Adults with T2D and food insecurity received […]

Read More
DiabetesLeave a Comment on 1249-OR: Medically Tailored Meals Lower Hemoglobin A1c: The Food as Medicine for Diabetes (FAME-D) Randomized Clinical Trial

1244-OR: Long Noncoding RNA: A New Partaker in the Removal of the Damaged Mitochondria in Diabetic Retinopathy

June 12, 2026 by sugaradmin

Introduction and Objective: Diabetes damages retinal mitochondria and impairs their removal by mitophagy, and these damaged mitochondria continue to accumulate. Diabetes also results in aberrant expression of many long noncoding RNAs (LncRNAs), the RNA transcripts with >200 nucleotides. These noncoding RNAs can interact with RNA, DNA and proteins, regulating many physiological processes. Among them, LncRNA […]

Read More
DiabetesLeave a Comment on 1244-OR: Long Noncoding RNA: A New Partaker in the Removal of the Damaged Mitochondria in Diabetic Retinopathy

1276-OR: GLP-1R Agonists Increase Irisin Levels in Patients with T2D through PKA/CREB-Dependent Muscle Stimulation

June 12, 2026 by sugaradmin

Introduction and Objective: Irisin is a hormone secreted by skeletal muscle following physical activity or exposure to excess saturated fatty acids, promoting energy expenditure and insulin secretion. Circulating irisin levels are reduced in patients with type 2 diabetes (T2D), while exogenous irisin administration improves glycemic control in diabetic mice. Interestingly, irisin and GLP-1 share pleiotropic […]

Read More
DiabetesLeave a Comment on 1276-OR: GLP-1R Agonists Increase Irisin Levels in Patients with T2D through PKA/CREB-Dependent Muscle Stimulation

1236-OR: Antenatal Continuous Glucose Monitoring and Perinatal Outcomes in Pregnancies Complicated by Type 2 Diabetes

June 12, 2026 by sugaradmin

Introduction and Objective: We compared perinatal outcomes among pregnancies complicated by type 2 diabetes (T2D) managed with continuous glucose monitoring (CGM) to self-monitored blood glucose (SMBG).Methods: Patients with pre-pregnancy T2D, singleton gestation, and delivery between 2018-2024 at two health systems were identified by ICD-10 codes. Patient demographics and outcomes were abstracted and compared between those […]

Read More
DiabetesLeave a Comment on 1236-OR: Antenatal Continuous Glucose Monitoring and Perinatal Outcomes in Pregnancies Complicated by Type 2 Diabetes

Posts navigation

Older posts
Newer posts

Recent Posts

  • Overlooked Signs You Shouldn’t Ignore
  • Many Obesity Drugs Do Not Improve Quality of Life
  • Prevalence, incidence, mortality, and years of life lost to diabetes from 1996 to 2024 in Denmark
  • Smelling Chocolate May Help Boost Workouts, Reduce Hunger
  • No Link To Prenatal Tylenol Use, Studies Confirm

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness